Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Akbar Dorgalaleh"'
Publikováno v:
Journal of Kerman University of Medical Sciences, Vol 30, Iss 4, Pp 229-232 (2023)
Background: Acute complications of transfusion are among leading causes of morbidity and mortality in chronically transfused patients. One of the main goals of the blood transfusion is reducing complications, improve blood safety and patient's health
Externí odkaz:
https://doaj.org/article/5eb5508011e74725a4d1b34a15bf3561
Publikováno v:
Journal of Cellular and Molecular Anesthesia, Vol 4, Iss 4, Pp 107-111 (2020)
Background: Congenital bleeding disorders (CBD) are a group of coagulopathies with different clinical and laboratory features. The prevalence of these disorders in different parts of the world is variable. Iran as a country with a high rate of parent
Externí odkaz:
https://doaj.org/article/964ac99313c742ee8fd8aaf71dd53f63
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 1, Pp 30-35 (2020)
Objective: First-time blood donors are the most common group of blood donors. They usually have different motivations for blood donation, some of which provoke the donors to hide risk factors of transfusion-transmissible infections (TTIs). Therefore,
Externí odkaz:
https://doaj.org/article/6e2a062c427940e9b2f7a388c4e9954c
Autor:
Maryam Daneshi, Tohid Naderi, Shadi Tabibian, Mahmood Shams, Jamal Rashidpanah, Akbar Dorgalaleh
Publikováno v:
Journal of Cellular and Molecular Anesthesia, Vol 3, Iss 4, Pp 146-154 (2019)
Congenital prothrombin deficiency is an extremely rare hemorrhagic disorder with estimated prevalence of 1 per 2,000,000 in the general population. Since the disorder is an autosomal recessive disorder, the disorder is more frequent in areas with hig
Externí odkaz:
https://doaj.org/article/e4d79e0230364d3e882856dae20489e4
Autor:
Hojat Shahraki, Akbar Dorgalaleh, Majid Fathi, Shadi Tabibian, Shahram Teimourian, Hasan Mollanoori, Alireza Khiabani, Farhad Zaker
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 14, Iss 4 (2020)
Abstract Congenital factor XIII (FXIII) deficiency is an extremely rare bleeding disorder (RBD) with estimated prevalence of one per 2 million in the general population. The disorder causes different clinical manifestations such as intracranial he
Externí odkaz:
https://doaj.org/article/4aecb31c93484d5aa343cf9a6ab2ba26
Publikováno v:
Journal of Cellular and Molecular Anesthesia, Vol 3, Iss 1, Pp 14-17 (2018)
Background: Congenital fibrinogen disorders (CFDs) comprise about 10% of rare bleeding disorders (RBDs). CFDs are divided into two groups of quantitative (afibrinogenemia and hypofibrinogenemia) with autosomal recessive inheritance pattern, and quali
Externí odkaz:
https://doaj.org/article/34dbc654d9534894be4239d21a17cbb2
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 9, p 2020 (2021)
Coronavirus disease 2019 (COVID-19), with a broad range of clinical and laboratory findings, is currently the most prevalent medical challenge worldwide. In this disease, hypercoagulability and hyperinflammation, two common features, are accompanied
Externí odkaz:
https://doaj.org/article/a94e6feba7a84b92ab5e5ec7183758fb
Publikováno v:
Journal of Cellular and Molecular Anesthesia, Vol 2, Iss 3, Pp 142-145 (2017)
Congenital factor XIII (FXIII) deficiency is a rare coagulopathy with the highest incidence in Iran. Iranian patients with FXIII deficiency (FXIIID) presented high rate of bleeding episodes, some of them are major cause of disability and mortality am
Externí odkaz:
https://doaj.org/article/9c33ba47e3a741c38bf7dae1261f8b55
Autor:
Akbar Dorgalaleh, Samira Esmaeili Reykandeh, Moreza Shamsizadeh, Behnaz Tavasoli, Eshagh Moradi
Publikováno v:
Iranian South Medical Journal, Vol 20, Iss 1, Pp 9-17 (2017)
Background: Factor XIII (FXIII) deficiency is a bleeding disorder and it inherited in an autosomal recessive manner. in areas where consanguineous marriage is common, it has high prevalence. Iran as a Middle East country comprise the high rate of con
Externí odkaz:
https://doaj.org/article/bb9e1cc1e7e04680816009219ddc951a
Autor:
Taregh Bamedi, Ghazaleh Dadashizadeh, Afsaneh Sarabandi, Shadi Tabibian, Mahmood Shams, Akbar Dorgalaleh
Publikováno v:
Journal of Cellular and Molecular Anesthesia, Vol 2, Iss 1, Pp 19-23 (2017)
Inhibitor development is a lifelong challenge for patients with bleeding disorders who received replacement therapy. Most commonly, inhibitor formation was observed in hemophilia A patients but patients with rare bleeding disorders (RBD) especially p
Externí odkaz:
https://doaj.org/article/800f8c9838ef4ea7aa59302ac4d5f5d3